Preliminary Program: Thursday, May 24
8 a.m.-Noon
CME Courses 92-94
9 a.m.-10:30 a.m.
Issue Workshops
IW77. Using Audiovisual Technology to Teach Behavioral SciencesChair: Jonathan S. Davine, M.D.
IW78. The Portrayal of Psychiatry in Recent American FilmChair: Steven E. Pflanz, M.D.
IW79. Innovative Child Programs Designed to Increase Access to Care in Diverse SettingsChair: Radmila Bogdanich, M.A.
IW80. Confidentiality in Overseas Settings: The Prioritization of the Individual Versus the Institution Versus the CommunityChair: Herbert L. Campbell, M.D.
IW81. Spiritually Augmented Well-Being Cognitive-Behavior TherapyChair: Russell F. D'Souza, M.D.
IW82. Psychiatric Issues in ArgentinaChair: Michelle B. Riba, M.D.
IW83. Buddhist Teachings and Techniques Applied to Disaster Relief: A Two-Year Follow-Up on Sri Lankan Tsunami VictimsChair: Syed S.A. Naqvi, M.D.
IW84. Minority Mental Health Policy Training: Developing Psychiatric Leaders for Careers About Cultural Competence and Disparities ReductionChair: Francis G. Lu, M.D.
IW85. Research on Procedural Memory: Practical Applications in Dementia CareChair: Sheila M. Loboprabhu, M.D.
IW86. Vietnam Veterans and the Iraq War: Is the Past Ever the Past?Chair: Laura C. Kordon, M.D.
IW87. A Role for Self-Awareness, Mindfulness, and Meditation in Psychiatric EducationChair: Robert S. Marin, M.D.
IW88. Frontier Psychiatry: Working With Street-Involved YouthChair: Seena S. Grewal, M.D.
IW89. Fibromyalgia: Current Understanding and Future DirectionsChair: Alan Z.A. Manevitz, M.D.
IW90. Perception and Color in Affective StatesChair: Lina I. Augius, M.D., M.P.H.
IW91. Medical Board of California Medical Expert Witness TrainingChair: Matthew F. Carroll, M.D.
IW92. Racist Reality: An Assessment of Representations of Minorities in Reality Television ProgrammingChair: Curley L. Bonds II, M.D.
IW93. The Four As of Collaborative Mental Health Care: Accessible, Accountable, Appropriate, and AffableChair: John M. Haggarty, M.D.
IW94. Refractory Schizophrenia: Treatment IssuesAmerican Association of Practicing Psychiatrists; Chair: Michael Y. Hwang, M.D.
11 a.m.-12:30 p.m.
IW95. Caregivers in Bipolar Families: Patients and Partners in TreatmentChair: Igor I. Galynker, M.D.
IW96. Gender Benders in Forensic PsychiatryChair: Susan J. Hatters-Friedman, M.D.
IW97. A Stigma of Much Substance: Educational Skills to Enhance Trainees' Attitudes and Approaches to Substance Use and Concurrent DisordersChair: Heather Flett, M.D.
IW98. Adapting the ACT Model for the Needs of Different Communities: A Comparative Case Study of Two Japanese and Canadian ACT TeamsChair: Wendy S. Chow, M.S.W.
IW99. Clinical Pathways for Mood and Anxiety DisordersChair: Waguih W. IsHak, M.D.
IW100. Finding Balance: The Application of Yoga to Mental HealthChair: Tara A. Klein, M.D.
IW101. Akathisia: An Elusive PhenomenonChair: Naveed Iqbal, M.D.
IW102. A Malpractice Lawsuit PrimerChair: Eugene Lowenkopf, M.D.
IW103. Multidisciplinary Treatment of Chronic PainChair: Vladimir Bokarius, M.D., Ph.D.
IW104. Addressing the Needs of Community-Dwelling Older Schizophrenic PersonsChair: Carl I. Cohen, M.D.
IW105. From Lab to Clinical Pratice: Biology and Treatment of Depression and Posttraumatic Stress DisorderChair: Meera Narasimhan, M.D.
IW106. The Ultimate Goal: A Modular Approach to Psychosis?Chair: Wolfgang Gaebel, M.D.
IW107. Case Studies Using Video Playback in Couples' TherapyChair: Ian E. Alger, M.D.
Scientific and Clinical Reports Session 28. Pharmacotherapy and Personality Disorders
82. Personality Traits and Prophylactic Treatment With Selective Serotonin Reuptake Inhibitors Sabrina J. Khan, M.D.
83. Olanzapine for the Treatment of Borderline Personality Disorder: A Flexible-Dose, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study S. Charles Schulz, M.D.
84. A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Mary C. Zanarini, Ed.D.
Session 29. Long-Term Outcomes of Schizophrenia
85. A 20-year, Multi-Follow-Up Study of Persecutory Delusions in Schizophrenia Martin Harrow, Ph.D.
86. Relationship Between Neurocognitive Performance and Instrumental Work Functioning in Schizophrenia and Other Disorders: A 20-year Prospective Longitudinal Study Linda S. Grossman, Ph.D.
87. Neurocognition, Complex Social Cognition, and Functional Outcome in Schizophrenia Joseph Ventura, Ph.D.
Session 30. Novel Approaches to Wellness
88. A New Kind of Psychiatry: Information Theory in the 21st Century David A. Rothstein, M.D.
89. Spirituality and Recovery From Panic Attacks Caroline B. Williams, M.D.
90. Fostering Spiritual Values and Well-Being: The Need in Psychiatry Russell F. D'Souza, M.D.
Session 31. Methological Issues in Psychiatric Disorders
91. Joint Crisis Plans for People With Psychosis: Economic Evaluation of an RCT Claire Henderson, M.D.
92. LOCF (Last Observation Carried Forward) and Distortion of Findings in a Psychotopic Drug Clinical Study Alex A. Cardoni, M.S.
93. Comparison of Depression and Personality Ratings by a Patient and Informant Regarding the Patient's Psychopathology Gavi Hollander, D.O.
Session 32. Trauma, Aggression, and Psychopathology
94. Clinical Differences Between Patients With Posttraumatic Stress Disorder With and Without Psychotic Symptoms Brian P Mika, M.D.
95. A Controlled Comparison Study of a yoga Breath-Based Program and a Client-Centered Exposure Therapy for Posttraumatic Stress Disorder and Depression in Survivors of Tsunami Disaster Patricia L. Gerbarg, M.D.
96. Exploratory Factor Analysis of Borderline Personality Disorder Criteria in Hispanic Men and Women With Substance Use Disorders Daniel F. Becker, M.D.
Session 33. Gender Issues in Psychiatric Disorders
97. Suicide Among Female Veterans in the General United States Population Bentson McFarland, M.D.
98. Comparison of Longitudinal Course of Illness Between Women and Men: A 25-year, Multi-Followup Study of Schizophrenia, Other Psychotic Disorders, and Nonpsychotic Depression Cherise Rosen, Ph.D.
99. Diagnostic and Gender Differences in Schizophrenia and Other Psychotic Disorders in First-Episode Psychosis Robert W. Marvin, M.D.
Session 34. Neuroscience and Neuropsychiatry in Mood Disorders
100. Brain-Derived Neurotrophic Factor Levels in Depressed Patients During Antidepressant Treatments Donatella Marazziti, M.D.
101. Information Processing in Bipolar Disorder During Remission Camilo J Ruggero, Ph.D.
102. Mitochondrial Function in the Anterior Cingulate and Treatment Response in MDD Dan V. Iosifescu, M.D.
Session 35. Antidepressants and Mood Disorders: Outcome Studies
103. Impact of Study Design on the Results of Continuation Studies of Antidepressants Mark Zimmerman, M.D.
104. The Effectiveness of Venlafaxine and Its Metabolite in Refractory Depressed Patients Patrick S. Mbaya, M.D.
105. Discontinuation of Antidepressant Prophylaxis—Are There Predictors? Tara M. Pundiak, M.D.
2 p.m.-5 p.m.
Symposia
S75. Culture as a Rationalization for Violence Against Women
Culture as a Rationalization for Violence Against Women in North America Gail E. Robinson, M.D. | |||||
Finding a Firm Base in a Sea of Cultural Relativism Sarah E. Romans, M.D. | |||||
Culture as a Rationalization for Violence Against Women—Pakistani Perspective Unaiza Niaz, M.D. | |||||
S76. The COMBINE Trial: Treatment of Alcohol Dependence From Bench to Bedside
Adapting the COMBINE Trial Findings for Clinical Practice: The 2006 NIAAA Clinicians Guide Mark L. Willenbring, M.D. | |||||
Primary Results From Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study Raymond F. Anton, M.D. | |||||
Relationship Between Patient Adherence and Treatment Outcomes in the COMBINE Study Allen Zweben, D.S.W. | |||||
Cost and Cost-Effectiveness of the COMBINE Study Gary Zarkin, Ph.D. | |||||
Predicting Drinking Outcomes in the COMBINE Study Dennis M. Donovan, Ph.D. | |||||
S77. Depression as Indicator and Focus of Treatment in Primary Care Clinics
From Dreaming to Doing: Essential Infrastructure Supports for Successful Mental Health/Primary Care Integration Nancy Bryant Wallis, Dr.P.H., L.C.S.W. | |||||
Addressing the Behavioral Health Needs of the Medically Underserved: Integrating Mental Health Services Into the Primary Care Setting Nora Cole, M.Ed. | |||||
Depression Treatment From a Primary Care Physician Perspective Paul E. Hubley, M.D. | |||||
A Psychiatry Perspective on Mental Health/Primary Care Integration Claudio O. Cabrejos, M.D. | |||||
S78. The Psychopathology of Personality: Perspectives From the Collaborative Longitudinal Personality Disorders Study (CLPS)
Longitudinal Course and Validity of Schizotypal Personality Disorder Thomas H. McGlashan, M.D. | |||||
Life Events and Relapse in Personality Disorders M. Tracie Shea, Ph.D. | |||||
Clinical Course and Impact of Avoidant Personality Disorder Andrew E. Skodol, M.D. | |||||
A Multidimensional Model of Obsessive-Compulsive Personality Disorder Anthony Pinto, Ph.D. | |||||
New Episodes and New Onsets of Major Depression in Borderline and Other Personality Disorders John G. Gunderson, M.D. | |||||
S79. Expanding NYS Prison Psychiatry
To Be Announced Zebulon C. Taintor, M.D. | |||||
To Be Announced Mike Hill | |||||
To Be Announced Al Shimkunas, Ph.D. | |||||
Inmates With Serious Mental Illness and Significant Disciplinary Issues Bruce B. Way, Ph.D. | |||||
Evolution of NyS Civil Commitment for Sex Offenders Bezalel Wurzberger, M.D. | |||||
S80. Neural Correlates of Psychodynamic Constructs
Neural Correlates of Psychodynamic Constructs Georg Northoff, M.D., Ph.D. | |||||
Neural Correlates of Cognitive Reappraisal in Borderline Personality Disorder Harold W. Koenigsberg, M.D. | |||||
Brain-Behavior Relationship in the Process of Establishing a Trusting Relationship in Individuals With a Diagnosis of Borderline Personality Disorder Peter Fonagy, Ph.D. | |||||
Neuroimaging of the Role of the Self and Identification in Emotion Regulation Philippe Fossati, M.D. | |||||
S81. Addressing Patients' Needs: Patient-Centered Diagnosis
Recording Multiple Psychiatric Diagnoses in an Individual Patient: Does It Lead to a More Comprehensive and Targeted Approach to Treatment? Mario Maj, M.D. | |||||
Biopsychosocial Thinking: Friend or Foe? G. Scott Waterman, M.D. | |||||
Therapeutic Diagnosing Roger Peele, M.D. | |||||
Patient-Centered Practice Guidelines: The Challenge John S. McIntyre, M.D. | |||||
S82. Optimum Treatment Duration in Early Psychosis
Early Intervention in the Initial Prodromal Phase: Results From the German Research Network on Schizophrenia Joachim Klosterkötter, M.D. | |||||
Intervention in Ultra-High-Risk Patients—The PACE Experience Patrick D. McGorry, M.D. | |||||
Are Antidepressants an Alternative for the Early Treatment of the Schizophrenia Prodrome? Barbara A. Cornblatt, Ph.D. | |||||
Duration of Long-Term Treatment in First-Episode Schizophrenia: Results From the German Research Network on Schizophrenia Wolfgang Gaebel, M.D. | |||||
Treatment Strategies in Remitted First-Episode Psychosis: The MESIFOS Trial Durk Wiersma, Ph.D. | |||||
S83. Model Psychiatry Residency Programs on Religion and Spirituality
Baylor College of Medicine Educational Programs in Psychiatry and Spirituality Linda B. Andrews, M.D. | |||||
The George Washington University Curriculum in Psychiatry and Spirituality James L. Griffith, M.D. | |||||
The University of California, Irvine, Psychiatry and Spirituality Curriculum for Resident Training Aaron Kheriaty, M.D. | |||||
S84. Suicide: Practical Patient Safety for the Doc From Risk Assessment to Risk Reduction
Suicide: Practical Patient Safety for the Doc From Risk Assessment to Risk Reduction Helena C. Kraemer, Ph.D. | |||||
Assessing and Overcoming the Failure Modes to Improve Suicide Risk Assessment and Risk Reduction Yad M. Jabbarpour, M.D. | |||||
To Be Announced Rory P. Houghtalen, M.D. | |||||
Evidence-Based Enhancement of Clinical Confidence in Suicide Risk Assessment Robert I. Simon, M.D. | |||||
S85. Combined Treatment With Psychotherapy and Medications: Research and Clinical Issues
Making the Choice: Medication or Psychotherapy Ellen Frank, Ph.D. | |||||
Integrating Pharmacotherapy With Psychodynamic Psychotherapy Steven P. Roose, M.D. | |||||
Research on Combined Treatment of Mood Disorders Michael E. Thase, M.D. | |||||
Specific and Nonspecific Treatment Factors in Clinical Trials for Depression Bret R. Rutherford, M.D. | |||||
S86. Children and War: Emotional and Psychiatric Consequences of War and Terror on Children and Adolescents
Overview: The Impact of War and Terror on Middle-Eastern Children and Adolescents Siham Muntasser, M.D. | |||||
Treatment of Children in War Elie G. Karam, M.D. | |||||
Dealing With Children's Anxiety and Fears During Wartime Alan Apter, M.D. | |||||
War Trauma and Child Mental Health in Iraqi Kurdistan Abdulbaghi Ahmad, Ph.D. | |||||
Considerations in Developing Therapeutic Services for Children Traumatized by War Dennis J. Hunt, Ph.D. | |||||
S87. The Psychocultural Foundations of Contemporary Terrorism
Killing for a Cause: An Integrated Social Science and Social Psychological Approach Dipak K. Gupta, Ph.D. | |||||
Understanding the Girls' Madrasas in Pakistan Farhana Ali, M.A. | |||||
Why We Are Losing the War on Terrorism George Everly, Ph.D. | |||||
Crimes of Obedience Jerrold M. Post, M.D. | |||||
Migrant youth and the Risk for Terrorism Stevan M. Weine, M.D. | |||||
S88. Work Outcome in Schizophrenia: Advances in Prediction and Intervention
Functional Capacity and Work Outcomes: Are There Any Specific Relationships? Philip D. Harvey, Ph.D. | |||||
Improving Work Outcome in Recent-Onset Schizophrenia: Supported Employment and Education, Workplace Skills Training, and Neurocognition Keith H. Nuechterlein, Ph.D. | |||||
Work Outcome in Schizophrenia: Advances in Prediction and Intervention Jean-Pierre Lindenmayer, M.D. | |||||
Neurocognitive Enhancement Therapy and Work Therapy: Productivity Outcomes at 6 and 12 months Joanna Fiszdon, Ph.D. | |||||
S89. Passages: Perspectives of Women Psychiatrists Negotiating Career Transitions
Retirement as a Life Passage Leah J. Dickstein, M.D. | |||||
The Juggling Act: Balancing the Scales at Mid-Career Carol A. Bernstein, M.D. | |||||
To Be Announced Joan A. Lang, M.D. | |||||
Pursuing Different Paths in Academic Psychiatry Laura W. Roberts, M.D. | |||||
To Thine Own Self Be True Melva I. Green, M.D. | |||||
Passages: Navigating Career Changes Within the Health Care Industry Kathy M. Vincent, M.D. | |||||
Passages: The Perspective of a Female MIT Navigating Through the Medical School and Residency years Navdeep K. Dhaliwal, M.D. ▪ | |||||
